Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-081628

Chief Development Officer sold 10,000 shares at $32.49 ($324,900)

  • Chief Development Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2024-07-01 Option exercise 10b5-1 +10,000 $21.65 $216,500 16,039 D
Guyer William Chief Development Officer 2024-07-01 Sale 10b5-1 −10,000 $32.49 $324,900 6,039 D
Derivatives
Guyer William Chief Development Officer 2024-07-01 Option exercise · Stock option (right to buy) 10b5-1 −10,000 490,000 D
Open-market sales · 10,000 sh · avg $32.49 · $324,900
Loading xslF345X05/ownership.xml…